Dec 28, 2024, 14:09
The new NCCN guidelines for immunotherapy-related toxicities
Elvina Almuradova, Associate Professor and Medical Oncologist Ambassador at European School of Oncology, shared a post on X:
“The new National Comprehensive Cancer Network (NCCN) guidelines address a wide range of immunotherapy-related toxicities, including those associated with ICI, CAR T-cell therapy, and lymphocyte engagers.”
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.
Authors: John A. Thompson, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 29, 2024, 11:15
Dec 29, 2024, 11:01
Dec 29, 2024, 10:44
Dec 29, 2024, 10:32
Dec 29, 2024, 10:21
Dec 29, 2024, 10:19
Dec 29, 2024, 10:16
Dec 29, 2024, 10:14
Dec 29, 2024, 10:10
Dec 29, 2024, 10:07